ARCHIVES

Cooperative Groups Advised to Prepare for 10 Percent Budget Cut, Begin Slowing Patient Accrual. Groups Say Cuts Would Jeopardize Clinical Trials Program.

This article is from The Cancer Letter archive.

Vol. 32 No. 38 | October 27, 2006

Download PDF Visit The Full Archive

Related Articles

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

April 29, 2005

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

May 9, 1997

If You Were On ODAC: Experts Suggest Questions For May 10 Advisory Meeting.

March 16, 2007

Freeman Reappointed President’s Cancer Panel Chairman

September 16, 1994

NCI to set separate payline for R01s over $700,000.

February 13, 2004

DeVita: No Decision Yet On FCRF Award

July 17, 1987